JAK2-unmutated erythrocytosis has a variety of etiologies, and identifying the underlying cause may prove helpful in cases where it is secondary to another condition such as polycythemia vera. The ...

Secondary polycythemia is the overproduction of red blood cells. It causes your blood to thicken, which increases the risk of a stroke. It’s a rare condition. The primary function of your red blood ...

Five year outcomes of clinically localized prostate cancer in patients with Human Immunodeficiency Virus No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the ...

Researchers explored the incidence of erythrocytosis in the first 20 months of testosterone therapy among people receiving gender-affirming hormone therapy (GAHT). Specifically, they conducted a ...

Sodium-glucose cotransporter 2 inhibitors (SGLT2is) increase hemoglobin and hematocrit levels, causing erythrocytosis in patients with type 2 diabetes without raising thrombotic event risks. The study ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “The largest increase in hematocrit was seen in the ...

Polycythemia vera is a chronic myeloproliferative neoplasm characterized by erythrocytosis. Rusfertide, an injectable peptide mimetic of the master iron regulatory hormone hepcidin, restricts the ...

We thank Dr. Mithoowani and colleagues for their excellent review on the investigation and management of erythrocytosis,1 which provides a comprehensive overview and approach to a common presentation ...

Relative to GLP-1RA and DPP-4 inhibitor use, SGLT2 inhibitor use was associated with an increased risk for erythrocytosis but not an increased risk for thrombosis in T2D. Among individuals with type 2 ...

Testosterone therapy can cause secondary erythrocytosis. Erythrocytosis can cause symptoms of hyperviscosity, such as headache, fatigue, blurred vision and paresthesias. A baseline value for ...